Derivative Valuation Loss Occurred
-
Derivative (convertible bond conversion/redemption rights) valuation loss of 3,678,751,742 won (19.35% of equity)
-
Cause: Accounting loss due to fair value increase of derivatives from CBs (6th,7th,9th series) following stock price rise
-
Non-cash accounting loss (K-IFRS) with no impact on operations or cash flow
-
Loss date: 2026-05-15
KOSDAQ Filing Information
-
-
Occurrence Of Loss On Derivative Transactions
-
Company: ADBIOTECH (179530)
-
Submission: ADBIOTECH Co.,Ltd.
-
Under KRX KOSDAQ Market Division
-
-
Shares: 19,679,630
-
Price: 2,485 KRW
-
Market Cap: 48.9 B KRW